Dyne Therapeutics, Inc.
NASDAQ:DYN
29.27 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||
Current Assets: | |||||||||||||||||
Cash & Cash Equivalents
| 121.626 | 172.147 | 200.825 | 300.852 | 14.632 | 8.124 | 365 | 1,776 | 505 | 1,870 | 843 | 348 | 396 | 291 | 471 | 693 | 328 |
Short Term Investments
| 1.474 | 83.865 | 175.746 | 44.462 | 0 | 0 | 32 | 130 | 100 | 78 | 25 | 13 | 69 | 106 | 78 | 87 | 104 |
Cash and Short Term Investments
| 123.1 | 256.012 | 376.571 | 345.314 | 14.632 | 8.124 | 397 | 1,906 | 605 | 1,948 | 868 | 361 | 465 | 397 | 549 | 780 | 432 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 513 | 386 | 402 | 270 | 420 | 108 | 6 | 230 | 212 | 340 | 426 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 445 | 445 | 597 | 208 | 181 | 101 | 57 | 121 | 141 | 184 | 199 |
Other Current Assets
| 6.275 | 9.582 | 5.821 | 3.773 | 0.127 | 0.034 | 169 | 250 | 341 | 248 | 216 | 473 | 144 | 1,496 | 1,136 | 1,499 | 606 |
Total Current Assets
| 129.375 | 256.012 | 382.392 | 345.314 | 14.759 | 8.158 | 1,524 | 2,987 | 1,945 | 2,674 | 1,685 | 1,043 | 672 | 2,244 | 2,038 | 2,803 | 1,663 |
Non-Current Assets: | |||||||||||||||||
Property, Plant & Equipment, Net
| 33.392 | 38.412 | 40.96 | 1.946 | 1.485 | 0.11 | 8,884 | 7,121 | 8,347 | 3,255 | 3,315 | 3,022 | 3,334 | 6,273 | 9,071 | 10,869 | 10,689 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 772 | 799 | 797 | 0 | 0 | 0 | 0 | 0 | 0 | 433 | 438 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 25 | 38 | 102 | 27 | 108 | 271 | 0 | 141 | 380 | 437 | 497 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 797 | 837 | 899 | 27 | 108 | 271 | 0 | 141 | 380 | 870 | 935 |
Long Term Investments
| 2.315 | 2.319 | 2.311 | 2.301 | 0 | 0 | 26 | 16 | 18 | 2 | 11 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 571 | 427 | 0 | 20 | 100 | 18 | 5 | 12 | 0 | 0 | 0 |
Other Non-Current Assets
| -0 | 9.582 | 0 | 3.773 | 0.191 | 0 | -31 | 1,665 | 330 | 5,254 | 72 | 181 | 116 | 1,343 | -536 | -329 | -66 |
Total Non-Current Assets
| 35.707 | 50.313 | 43.271 | 8.02 | 1.676 | 0.11 | 10,247 | 10,066 | 9,594 | 8,558 | 3,606 | 3,492 | 3,455 | 7,769 | 8,915 | 11,410 | 11,558 |
Total Assets
| 165.082 | 306.325 | 425.663 | 353.334 | 16.436 | 8.268 | 11,771 | 13,053 | 11,539 | 11,232 | 5,291 | 4,535 | 4,127 | 10,013 | 10,953 | 14,213 | 13,221 |
Liabilities & Equity: | |||||||||||||||||
Current Liabilities: | |||||||||||||||||
Account Payables
| 22.936 | 5.259 | 4.031 | 3.44 | 1.256 | 0.518 | 367 | 332 | 292 | 216 | 329 | 112 | 15 | 134 | 181 | 303 | 292 |
Short Term Debt
| 4.72 | 4.61 | 3.893 | 0 | 0 | 0 | 105 | 201 | 83 | 31 | 13 | 29 | 4 | 148 | 807 | 64 | 51 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 64 | 3 | 3 | 4 | 274 | 1 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 7 | 5 | 29 | 20 | 100 | 95 | 5 | 12 | 6 | 6 | 45 |
Other Current Liabilities
| 23.439 | 18.219 | 20.799 | 7.527 | 1.102 | 0.193 | 570 | 378 | 408 | 414 | 279 | 111 | 135 | 1,271 | 853 | 1,329 | 611 |
Total Current Liabilities
| 51.095 | 28.088 | 28.723 | 10.967 | 2.358 | 0.711 | 1,049 | 916 | 812 | 681 | 721 | 347 | 159 | 1,565 | 1,847 | 1,702 | 999 |
Non-Current Liabilities: | |||||||||||||||||
Long Term Debt
| 22.695 | 25.873 | 28.743 | 0 | 0 | 3.375 | 8,328 | 8,778 | 7,206 | 7,075 | 1,979 | 1,386 | 584 | 4,426 | 807 | 64 | 51 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 7 | 5 | 29 | 20 | 100 | 95 | 5 | 641 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0.042 | 9.061 | 146 | 170 | 183 | 217 | 178 | 257 | 145 | 336 | 359 | 500 | 388 |
Total Non-Current Liabilities
| 22.695 | 25.873 | 28.743 | 0 | 0.042 | 12.436 | 8,481 | 8,953 | 7,418 | 7,312 | 2,257 | 1,738 | 734 | 5,403 | 1,166 | 564 | 439 |
Total Liabilities
| 73.79 | 53.961 | 57.466 | 10.967 | 2.4 | 13.147 | 9,870 | 11,011 | 8,618 | 8,209 | 3,081 | 2,032 | 3,015 | 7,267 | 7,974 | 9,728 | 8,692 |
Equity: | |||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 27.429 | 9.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.006 | 0.006 | 0.006 | 0.005 | 0.001 | 0.001 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 5 | 5 |
Retained Earnings
| -632.51 | -396.573 | -228.474 | -79.183 | -19.746 | -4.887 | -1,851 | -1,927 | -686 | -736 | -463 | -107 | -4,841 | -3,196 | 0 | 0 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | -0.571 | -0.269 | -0.027 | -0 | -0.024 | 32 | 21 | 19 | 20 | 58 | 11 | -53 | -53 | -150 | -215 | -25 |
Other Total Stockholders Equity
| 723.796 | 649.502 | 596.934 | 421.572 | 6.352 | -9.03 | 3,719 | 3,947 | 3,587 | 3,738 | 2,614 | 2,598 | 6,005 | 5,994 | 3,046 | 4,725 | 4,526 |
Total Shareholders Equity
| 91.292 | 252.364 | 368.197 | 342.367 | 14.036 | -4.879 | 1,901 | 2,042 | 2,921 | 3,023 | 2,210 | 2,503 | 1,112 | 2,746 | 2,902 | 4,515 | 4,506 |
Total Equity
| 91.292 | 252.364 | 368.197 | 342.367 | 14.036 | -4.879 | 1,901 | 2,042 | 2,921 | 3,023 | 2,210 | 2,503 | 1,112 | 2,746 | 2,902 | 4,515 | 4,506 |
Total Liabilities & Shareholders Equity
| 165.082 | 306.325 | 425.663 | 353.334 | 16.436 | 8.268 | 11,771 | 13,053 | 11,539 | 11,232 | 5,291 | 4,535 | 4,127 | 10,013 | 10,953 | 14,213 | 13,221 |